Haemonetics (HAE) announces the first treatment of patients in Germany with the VASCADE MVP Venous Vascular Closure system.
Investors looking for stocks in the Medical - Products sector might want to consider either Haemonetics (HAE) or Stryker (SYK). But which of these two stocks presents investors with the better value o

New Strong Buy Stocks for August 10th

08:30am, Thursday, 10'th Aug 2023
GM, KB, CRBG, AXS and HAE have been added to the Zacks Rank #1 (Strong Buy) List on August 10, 2023.
The robust volume growth and price benefits in the Plasma business drive Haemonetics' (HAE) fiscal first-quarter performance.
While the top- and bottom-line numbers for Haemonetics (HAE) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare
Haemonetics (HAE) came out with quarterly earnings of $1.05 per share, beating the Zacks Consensus Estimate of $0.76 per share. This compares to earnings of $0.58 per share a year ago.
Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should lend support to the Zacks Medical-Products industry. ABT, SYK, ZBH and HAE are well po
Investors interested in stocks from the Medical - Products sector have probably already heard of Haemonetics (HAE) and Stryker (SYK). But which of these two stocks presents investors with the better v
Haemonetics (HAE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Haemonetics (HAE) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, HAE broke through the 20-day moving average, which suggests a shor
Haemonetics (HAE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
BOSTON , July 10, 2023 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish first quarter fiscal year 2024 financial results at 6:00 am ET on Tuesday, Augu
Investors interested in stocks from the Medical - Products sector have probably already heard of VAREX IMAGING (VREX) and Haemonetics (HAE). But which of these two companies is the best option for tho
Haemonetics (HAE) receives FDA clearance for the advancements made to the NexSys PCS plasma collection system.
Investors interested in Medical - Products stocks are likely familiar with VAREX IMAGING (VREX) and Haemonetics (HAE). But which of these two stocks offers value investors a better bang for their buck
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE